collaborators

5 papers

q-bio.QM2026

Kidney function and kidney failure prediction in a large multiethnic population

James A. Diao, Morgan Sanchez, Adir Sommer +7

Background: Patients with chronic kidney disease (CKD) experience worsening kidney function and develop subsequent kidney failure at different rates. Accurate estimates of a patien…

q-bio.QM2026

Laboratory Trajectories Improve Kidney Failure Risk Estimation

Morgan Sanchez, James A. Diao, Jesse Cummings +8

Accurate kidney failure risk assessment is critical to timely intervention in chronic kidney disease (CKD). Existing equations (e.g. Kidney Failure Risk Equation; KFRE) rely on sin…

cs.LG2026

Learning Normal Representations for Blood Biomarkers

Aashna P. Shah, Michelle M. Li, Yash Lal +9

Blood-based biomarkers underpin clinical diagnosis and management, yet their interpretation relies largely on fixed population reference intervals that ignore stable, intra-patient…

q-bio.OT2026

Statin Recommendations among US Adults with the 2026 Dyslipidemia Guidelines

James A. Diao, Thomas A. Buckley, Andrew Z. Zhou +3

Importance: The 2026 multisociety dyslipidemia guideline recommended the PREVENT equations in place of the PCE equations, introduced 30-year risk assessment as a new treatment path…

q-bio.QM2025

Disentangling Proxies of Demographic Adjustments in Clinical Equations

Aashna P. Shah, James A. Diao, Emma Pierson +2

The use of coarse demographic adjustments in clinical equations has been increasingly scrutinized. In particular, adjustments for race have sparked significant debate with several…